Ixovex-1 Single Agent and Combination Therapy

NCT06549946 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Head and Neck Cancer

Interventions

BIOLOGICAL: Ixovex-1
BIOLOGICAL: Pembrolizumab

Sponsor

Psivac Ltd

Collaborators

[object Object]